共 135 条
[1]
Dirnagl U(1999)Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 22 391-397
[2]
Iadecola C(2010)Acute pathophysiological processes after ischaemic and traumatic brain injury Best Pract Res Clin Anaesthesiol 24 495-509
[3]
Moskowitz MA(2019)Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 50 e344-e418
[4]
Kunz A(2010)Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review J Neurochem 115 845-853
[5]
Dirnagl U(2012)Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial Exp Neurol 238 243-253
[6]
Mergenthaler P(2006)Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2– mediated protection of brain after experimental cerebral ischemia in rat Brain Res 1096 196-203
[7]
Powers WJ(2008)Peroxisome proliferator-activated receptors gamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia Eur J Neurosci 28 1786-1794
[8]
Rabinstein AA(2009)Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia J Neurosci 29 6186-6195
[9]
Ackerson T(2006)Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats FASEB J 20 1162-1175
[10]
White AT(2010)Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain J Hypertens 28 1488-1497